Alpha memo: resveratrol exercise animal-to-human boundary

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Explicitly identify the 3xTg Alzheimer's disease model vs healthy aged men as a potential axis of the split, alongside species, modality, and endpoint.
2. Clarify in the abstract or synthesis that Receipt 1 tested resveratrol+exercise jointly in an AD mouse model, so the 'anchor' is not resveratrol alone but a combined intervention in a disease model.
3. Soften or contextualize the 'Why this is surprising' framing given that animal-to-human translation failures for resveratrol are well established.
4. Add the disease-model vs healthy-population distinction to the bounded contrast axes list.

Major issues

• The bounded contrast claims Receipt 1 axes include 'mice, mouse, exercise, training, cardiac, function' and Receipt 2 axes include 'men, aged, human, endurance, exercise, training, metabolic, inflammatory,' but the memo does not explicitly acknowledge that Receipt 1 is an Alzheimer's disease model (3xTg) while Receipt 2 is healthy aged men. The disease-model vs healthy-population difference is arguably the most material axis driving the split, and it is buried rather than surfaced.

Minor issues

• The title says 'resveratrol exercise animal-to-human boundary' but Receipt 1 also involves exercise training as a co-intervention, so the boundary is not purely resveratrol but resveratrol+exercise vs exercise-alone.
• The abstract says resveratrol 'made us expect... would travel cleanly' but Receipt 1 actually reports that BOTH resveratrol and exercise were beneficial in mice, so the surprise framing slightly misrepresents what Receipt 1 supports.
• 'Why this is surprising' overstates the novelty; the failure of resveratrol to translate from animal to human is a well-documented pattern, not a surprising new boundary.
• The falsifier section is generic and could be more specific about what endpoint would need to match.

Reviewer note

The memo correctly identifies a bounded two-receipt contrast and stays within the cited evidence. Receipt 1 (3xTg AD mice, 2019) shows resveratrol + exercise benefit on cardiac/aortic function; Receipt 2 (healthy aged men, 2014) shows exercise but not resveratrol improves skeletal muscle metabolic/inflammatory markers. The signal is clear and source-grounded. However, the memo buries the most material axis: Receipt 1 is a disease model (Alzheimer's 3xTg mice) while Receipt 2 is healthy aged humans. This disease-model vs healthy-population distinction is arguably more important than the species boundary alone and should be explicitly surfaced. The novelty framing ('why this is surprising') is mildly overstated since resveratrol translation failures are well documented. Source grounding is strong — both DOIs resolve and excerpts directly support the claims. The memo is mostly correct but needs the AD-disease-model axis made explicit and the surprise framing tempered. Revise, not reject, because the core bounded signal is valid and the fixes are bounded.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: fallback_tiebreak_failed_conservative

Prompt: reviewer-v11-research-synthesis